Celltrion

Latest news

• Celltrion obtains U.S. Phase 3 clinical trial approval for ‘Zymfentra’ seeking expansion for rheumatoid arthritis indications (opens in a new tab)

  더바이오 · Oct 2, 2026

• Celltrion to Expand Global Supply Chain and CDMO Partnerships at CPHI, Accelerating Push to Become Global Drugmaker (opens in a new tab)

  v.daum.net · Sep 29, 2026

• Celltrion wins U.S. Phase 3 clinical trial approval for ‘Zymfentra’ in rheumatoid arthritis, expanding indications (opens in a new tab)

  더바이오 · Sep 27, 2026

• How Celltrion's Remsima Became Japan's Top Infliximab: A 2026 Market Analysis (opens in a new tab)

  뉴스1 · Sep 18, 2026

• Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra (opens in a new tab)

  뉴스1 · Sep 16, 2026

• Celltrion Launches U.S. Phase 4 Trial of High-Dose Zymfentra (opens in a new tab)

  팜이데일리 · Sep 15, 2026

• “Second-Half Performance to Outpace First Half”… Celltrion Expected to Exceed Full-Year Revenue Target (opens in a new tab)

  뉴스1 · Sep 4, 2026